Results of the MIDAS trial: Effects of docosahexaenoic
on physiological and safety parameters in age-related cognitive
decline.
Play the video
Click the arrow button on the player.
Join ISTAART
Alzheimer's Association ISTAART is a professional society for those involved in dementia research and treatment. Members receive a $125 discount on ICAD registration. Learn more.
Sign Up for E-mails!
If you would like to receive updates on the conference via e-mail, please send a request.
